Skip to main content

Memory, Delayed

0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
Auditory and Electrical StimulationN/A1 trial
Deep Brain StimulationN/A1 trial
Active Trials
NCT05452122Recruiting150Est. Aug 2026
NCT04874220Recruiting70Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsAuditory and Electrical Stimulation
Angeles TherapeuticsDeep Brain Stimulation

Clinical Trials (2)

Total enrollment: 220 patients across 2 trials

NCT05452122Angeles TherapeuticsAuditory and Electrical Stimulation

Decoding and Selective Modulation of Human Memory During Awake/Sleep Cycles

Start: Jul 2022Est. completion: Aug 2026150 patients
N/ARecruiting
NCT04874220Angeles TherapeuticsDeep Brain Stimulation

Neural Correlates of Real World Spatial Navigation in Humans

Start: Sep 2020Est. completion: Jun 202670 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 220 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.